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05.15.01 Controlled Drug Delivery Systems
Matthew Griffith, Ashley Hartsell, Garrick Friesen, Hardeep Saluja, Kaci Hall,
Tanya Harrelson,
Southwestern Oklahoma State University
Substantial advancements have been made in controlled drug delivery systems in the last twenty to
thirty years due to contributing advancements in biopharmaceutics, pharmacokinetics, and
pharmacodynamics. In delivering optimal drug therapy, the desire is to maintain a drug concentration
within the therapeutic window to ensure efficacy and minimize toxicity. Research has shown that dosing
more than once to twice daily in order to achieve optimal therapy results in less patient compliance.
Therefore, extensive research and attention has been directed to the development of controlled drug
delivery systems. These dosage forms allow for controlling the rate of drug delivery, sustaining the
duration of therapeutic activity and targeting the delivery of drugs to tissues among other advantages.
The objective is to display the five common controlled drug delivery systems used in optimizing drug
therapy and increasing patient compliance. These five dosage forms range over a short time span in
relation to the history of pharmaceutics, but each has been developed to improve therapy in one of the
three manners previously listed. The controlled drug delivery systems included are enteric coating,
micro-encapsulation, transdermal delivery, osmotic pumps, and intravaginal rings. The benefits of
modified release dosage forms can result in increased patient compliance, decreased side effects,
decreased spikes in concentration, enhanced bioavailability, the ability to target specific organs or
05.15.02 Health Challenges in Tanzania: Report of Public Health Screening
Initiative
Linda Rider,
University of Central Oklahoma
A team of healthcare workers traveled to Tanzania to facilitate a primary health screening initiative with
citizens of Tanzania. In Tanzania the culture is rich and diverse, and there are numerous challenges to
effective health care. Findings both from experience and from other resources are compared and
contrasted between health experiences in the United States and Tanzania. This poster is a
presentation of the challenges and findings of the health screening activities. The most common
findings were hypertension, high blood sugar (diabetes), anemia, and heart murmurs in children.
05.15.03 Dissolution Profile of Indomethacin Formulations with Complexation of
Counter-ions in a PVP Matrix
Andrew Mansour, Hardeep Saluja, John Thompson,
Southwestern Oklahoma State University
Crystalline Indomethacin (IMC), a Non-steroidal Anti-Inflammatory Drug (NSAID), suffers from poor
solubility in an aqueous environment. A strategy to increase the solubility of IMC and similar drugs has
been to create an amorphous solid dispersion of the drug. The amorphous form of the Active
Pharmaceutical Ingredient (API) allows for a less ordered structure, and requires less energy to
dissolve the solid form into the solvent. Amorphous formulations undergo a solid-state transformation,
spontaneously converting back to the more stable crystalline form, decreasing solubility. A strategy to
slow this process is to incorporate the API into complexes with polymers such as Polyvinylpyrrolidone
(PVP). In this study we compared the effect of adding an HCl salt to the PVP-indomethacin complex in
an effort to improve solubility. Formulations were dissolved under heated solvent @ 50 C, and
evaporated under vacuum with a Rotovap to solidify an amorphous solid. The solid formulation was
scraped, oven-dried, and stored in a tightly sealed container at room temperature. Dissolution studies
were performed using a Varian 7100 dissolution apparatus per USP methods. IR spectra of each
sample were recorded in tandem with dissolution procedures to differentiate the absorption differences
between the samples. The analysis of the data showed a more rapid initial solubility of the IMC-PVP-
Counter-ion complex, but all compounds experienced a drop in concentration after the 3-hour mark.
